Ignite Creation Date:
2024-07-17 @ 10:58 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470763
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-14
Brief Title:
A Study Evaluating ANV600 Single Agent or in Combination with Pembrolizumab in Participants with Advanced Solid Tumors EXPAND-1
Sponsor:
Organization:
Anaveon AG